Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Aug 19, 2009

Mylan Files Lawsuit Against Pittsburgh Post-Gazette

Aug 18, 2009

Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment

Aug 13, 2009

Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48-Year Exemplary Record of Quality

Aug 10, 2009

Mylan Receives FDA Approval for Generic Version of Migraine Treatment Imitrex(R)

Aug 06, 2009

President Clinton and Mylan Chairman and CEO Robert J. Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug-Resistant HIV in Developing Countries

Jul 30, 2009

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

Jul 29, 2009

Mylan Chairman and CEO Robert J. Coury to Ring NASDAQ Stock Market Closing Bell

Jul 29, 2009

Mylan Announces Enhancements to Executive Management Team

Jul 29, 2009

Mylan Announces Enhancements to Executive Management Team

Jul 28, 2009

Mylan Reports That the FDA Determined That All Accusations Were Unfounded

Pagination

First page
Previous page
…
Page 83
Page 84
Page 85
Page 86
Current page 87
Page 88
Page 89
Page 90
Page 91
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.